All effects are dose-dependent and typically resolve after dosage adjustment
Never freeze reconstituted peptide solutions, as the freeze-thaw cycle can damage the peptide structure
To reconstitute a peptide vial: (1) Allow the vial to reach room temperature, (2) Sterilize the rubber stopper with an alcohol prep pad, (3) Draw the calculated amount of bacteriostatic water into a sterile syringe, (4) Slowly inject the bacteriostatic water down the inside wall of the vial to avoid foaming, (5) Gently roll the vial to dissolvenever shake, (6) Verify the solution is clear with no visible particles, and (7) Store refrigerated at 2-8C protected from light

Benzyl Alcohol Considerations While benzyl alcohol is an FDA-approved preservative for multi-dose vial formulations, it is important to note that: Benzyl alcohol has been associated with adverse effects in neonates (very young infants) at high concentrations when used as a preservative in injectable products Use in pediatric or neonatal populations should follow institutional guidelines and medical supervision Practitioners should be aware of any patient-specific contraindications or sensitivities Product use should always align with the prescribing information and clinical judgment of licensed healthcare providers Storage and Handling Requirements Temperature: Store at controlled room temperature (typically 6877F / 2025C)

Technical requirements for Medicare NDC entry: Format: 11-digit NDC in 5-4-2 configuration Electronic claim (837P): enter in Loop 2410, Segment LIN, with qualifier N4 Paper claim (CMS-1500): enter in Box 19 Unit of measure qualifier: UN for units, ML for milliliters, or GR for grams Quantity reported: the actual amount administered, not the full vial size Commercial payer NDC requirements work differently